Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1978 Apr;54(630):231–243. doi: 10.1136/pgmj.54.630.231

A basis for migraine therapy- the autonomic theory reappraised.

E S Johnson
PMCID: PMC2425244  PMID: 26908

Abstract

The concept that migraine results from an initial vasoconstriction due to increased release of noradrenaline from the sympathetic nerves to cranial blood vessels has been reappraised in the light of recently acquired knowledge of the mechanisms of action of drugs used in the treatment of migraine, physiological and pharmacological evidence implicating noradrenaline, and the observations by others that several migraine variants may be associated with some degree of sympathetic overactivity. If the theory is correct, it suggests that both prophylaxis and management of the acute condition should be possible by means of selective alpha-adrenoceptor antagonism. The use of drugs with potentially dangerous vasoconstrictor properties appears to be unnecessary. The suggestion is made that the increased adrenergic activity might result from changes within the hypothalamus.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMIN A. H., CRAWFORD T. B., GADDUM J. H. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J Physiol. 1954 Dec 10;126(3):596–618. doi: 10.1113/jphysiol.1954.sp005229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adam H. M., Hye H. K. Concentration of histamine in different parts of brain and hypophysis of cat and its modification by drugs. Br J Pharmacol Chemother. 1966 Oct;28(1):137–152. doi: 10.1111/j.1476-5381.1966.tb01880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aellig W. H. Influence of ergot compounds on compliance of superficial hand veins in man. Postgrad Med J. 1976;52SUPPL:21–23. [PubMed] [Google Scholar]
  5. Alps B. J., Borrows E. T., Johnson E. S., Staniforth M. W., Wilson A. B. A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine, and quinidine. Cardiovasc Res. 1972 May;6(3):226–234. doi: 10.1093/cvr/6.3.226. [DOI] [PubMed] [Google Scholar]
  6. Anthony M., Hinterberger H., Lance J. W. Plasma serotonin in migraine and stress. Arch Neurol. 1967 May;16(5):544–552. doi: 10.1001/archneur.1967.00470230096013. [DOI] [PubMed] [Google Scholar]
  7. Anthony M., Lance J. W. Monoamine oxidase inhibition in the treatment of migraine. Arch Neurol. 1969 Sep;21(3):263–268. doi: 10.1001/archneur.1969.00480150053007. [DOI] [PubMed] [Google Scholar]
  8. Anthony M., Lance J. W., Somerville B. A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine. Med J Aust. 1972 Jun 24;1(26):1343–1346. doi: 10.5694/j.1326-5377.1972.tb116454.x. [DOI] [PubMed] [Google Scholar]
  9. Armstrong J. M., Boura A. L. Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Br J Pharmacol. 1973 Apr;47(4):850–852. doi: 10.1111/j.1476-5381.1973.tb08214.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Baum T., Shropshire A. T. Studies on the centrally mediated hypotensive activity of guanabenz. Eur J Pharmacol. 1976 May;37(1):31–44. doi: 10.1016/0014-2999(76)90005-4. [DOI] [PubMed] [Google Scholar]
  11. Blau J. N., Cumings J. N. Method of precipitating and preventing some migraine attacks. Br Med J. 1966 Nov 19;2(5524):1242–1243. doi: 10.1136/bmj.2.5524.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bolme P., Corrodi H., Fuxe K., Hökfelt T., Lidbrink P., Goldstein M. Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Eur J Pharmacol. 1974 Sep;28(1):89–94. doi: 10.1016/0014-2999(74)90116-2. [DOI] [PubMed] [Google Scholar]
  13. CHAPMAN L. F., RAMOS A. O., GOODELL H., SILVERMAN G., WOLFF H. G. A humoral agent implicated in vascular headache of the migraine type. Arch Neurol. 1960 Sep;3:223–229. doi: 10.1001/archneur.1960.00450030001001. [DOI] [PubMed] [Google Scholar]
  14. Cambridge D., Davey M. J., Massingham R. Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]. Br J Pharmacol. 1977 Mar;59(3):514P–515P. [PMC free article] [PubMed] [Google Scholar]
  15. Cameron I. R., Caronna J. The effect of local changes in potassium and bicarbonate concentration on hypothalamic blood flow in the rabbit. J Physiol. 1976 Nov;262(2):415–430. doi: 10.1113/jphysiol.1976.sp011602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Campus S., Fabris F., Rappelli A., Gastaldi L., Gai V., Nattero G. Escrezione urinaria di acido 5-idrossiindolacetico durante crisi cefalalgica indotta da trinitroglicerina. Boll Soc Ital Biol Sper. 1967 Dec 31;43(24):1844–1847. [PubMed] [Google Scholar]
  17. Collier J. G., Nachev C., Robinson B. F. Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin Sci. 1972 Sep;43(3):455–467. doi: 10.1042/cs0430455. [DOI] [PubMed] [Google Scholar]
  18. Collis M. G., Alps B. J. The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations. J Pharm Pharmacol. 1973 Aug;25(8):621–628. doi: 10.1111/j.2042-7158.1973.tb10648.x. [DOI] [PubMed] [Google Scholar]
  19. Combining hypotensive drugs. Br Med J. 1967 Mar 4;1(5539):550–550. [PMC free article] [PubMed] [Google Scholar]
  20. Corbett J. L., Eidelman B. H., Debarge O. Modification of cerebral vasoconstriction with hyperventilation in normal man by thymoxamine. Lancet. 1972 Sep 2;2(7775):461–463. doi: 10.1016/s0140-6736(72)91856-9. [DOI] [PubMed] [Google Scholar]
  21. Coupar I. M., Kirby M. J. The effect of clonidine on human isolated smooth muscle. Eur J Pharmacol. 1972 Jan;17(1):50–58. doi: 10.1016/0014-2999(72)90268-3. [DOI] [PubMed] [Google Scholar]
  22. Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
  23. Curzon G., Barrie M., Wilkinson M. I. Relationships between headache and amine changes after administration of reserpine to migrainous patients. J Neurol Neurosurg Psychiatry. 1969 Dec;32(6):555–561. doi: 10.1136/jnnp.32.6.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. D'Alecy L. G., Feigl E. O. Sympathetic control of cerebral blood flow in dogs. Circ Res. 1972 Aug;31(2):267–283. doi: 10.1161/01.res.31.2.267. [DOI] [PubMed] [Google Scholar]
  25. DALESSIO D. J. On migraine headache: serotonin and serotonin antagonism. JAMA. 1962 Jul 28;181:318–321. [PubMed] [Google Scholar]
  26. DAVEY M. J., FARMER J. B. The mode of action of tyramine. J Pharm Pharmacol. 1963 Mar;15:178–182. doi: 10.1111/j.2042-7158.1963.tb12767.x. [DOI] [PubMed] [Google Scholar]
  27. DUKES H. T., VIETH R. G. CEREBRAL ARTERIOGRAPHY DURING MIGRAINE PRODROME AND HEADACHE. Neurology. 1964 Jul;14:636–639. doi: 10.1212/wnl.14.7.636. [DOI] [PubMed] [Google Scholar]
  28. Ekbom K., Lundberg P. O. Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis. Headache. 1972 Apr;12(1):15–17. doi: 10.1111/j.1526-4610.1972.hed1201015.x. [DOI] [PubMed] [Google Scholar]
  29. Fanchamps A. The role of humoral mediators in migraine headache. Can J Neurol Sci. 1974 Aug;1(3):189–195. doi: 10.1017/s0317167100119249. [DOI] [PubMed] [Google Scholar]
  30. Fozard J. R. The animal pharmacology of drugs used in the treatment of migraine. J Pharm Pharmacol. 1975 May;27(5):297–321. doi: 10.1111/j.2042-7158.1975.tb09448.x. [DOI] [PubMed] [Google Scholar]
  31. Friedman A. P. Migraine headaches. JAMA. 1972 Dec 11;222(11):1399–1402. doi: 10.1001/jama.222.11.1399. [DOI] [PubMed] [Google Scholar]
  32. Frohlich E. D., Tarazi R. C., Dustan H. P., Page I. H. The paradox of beta-adrenergic blockade in hypertension. Circulation. 1968 Mar;37(3):417–423. doi: 10.1161/01.cir.37.3.417. [DOI] [PubMed] [Google Scholar]
  33. Ghose K., Coppen A., Carrol D. Intravenous tyramine response in migraine before and during treatment with indoramin. Br Med J. 1977 May 7;1(6070):1191–1193. doi: 10.1136/bmj.1.6070.1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gonsalves A., Johnson E. S. Possible mechanism of action of beta-phenethylamine in migraine. J Pharm Pharmacol. 1977 Oct;29(10):646–646. doi: 10.1111/j.2042-7158.1977.tb11427.x. [DOI] [PubMed] [Google Scholar]
  35. Gotoh F., Kanda T., Sakai F., Yamamoto M., Takeoka T. Serum dopamine-beta-hydroxylase activity in migraine. Arch Neurol. 1976 Sep;33(9):656–657. doi: 10.1001/archneur.1976.00500090062012. [DOI] [PubMed] [Google Scholar]
  36. Grant E. C., Pryse-Davies J. Effect of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphatases. Br Med J. 1968 Sep 28;3(5621):777–780. doi: 10.1136/bmj.3.5621.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Görlitz B. D., Frey H. H. Letter: Comparison of the blocking effects of antagonists of adrenaline and 5-hydroxytryptamine on their mutual receptors. J Pharm Pharmacol. 1973 Aug;25(8):651–653. doi: 10.1111/j.2042-7158.1973.tb10654.x. [DOI] [PubMed] [Google Scholar]
  38. Hares P., James I. M., Griffith D. The effect of acebutolol on the cerebral circulation of man. Br J Clin Pharmacol. 1977 Jun;4(3):373–375. doi: 10.1111/j.1365-2125.1977.tb00727.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Henderson W. R., Raskin N. H. "Hot-dog" headache: individual susceptibility to nitrite. Lancet. 1972 Dec 2;2(7788):1162–1163. doi: 10.1016/s0140-6736(72)92591-3. [DOI] [PubMed] [Google Scholar]
  40. Hoff J. T., Harper M., Sengupta D., Jennett B. Effect of alpha-adrenergic blockade on response of cerebral circulation to hypocapnia in the baboon. Lancet. 1972 Dec 23;2(7791):1337–1339. doi: 10.1016/s0140-6736(72)92778-x. [DOI] [PubMed] [Google Scholar]
  41. Hsu L. K., Crisp A. H., Kalucy R. S., Koval J., Chen C. N., Carruthers M., Zilkha K. J. Early morning migraine. Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and sleep encephalographs. Lancet. 1977 Feb 26;1(8009):447–451. doi: 10.1016/s0140-6736(77)91942-0. [DOI] [PubMed] [Google Scholar]
  42. Ingvar D. H., Risberg J. Increase of regional cerebral blood flow during mental effort in normals and in patients with focal brain disorders. Exp Brain Res. 1967;3(3):195–211. doi: 10.1007/BF00235584. [DOI] [PubMed] [Google Scholar]
  43. Iversen L. L., Salt P. J. Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br J Pharmacol. 1970 Nov;40(3):528–530. doi: 10.1111/j.1476-5381.1970.tb10637.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Iwayama T., Furness J. B., Burnstock G. Dual adrenergic and cholinergic innervation of the cerebral arteries of the rat. An ultrastructural study. Circ Res. 1970 May;26(5):635–646. doi: 10.1161/01.res.26.5.635. [DOI] [PubMed] [Google Scholar]
  45. KIMBALL R. W., FRIEDMAN A. P. Further studies of neurohumoral agents in patients with vascular headaches. Neurology. 1961 Feb;11:116–119. doi: 10.1212/wnl.11.2.116. [DOI] [PubMed] [Google Scholar]
  46. KIMBALL R. W., FRIEDMAN A. P., VALLEJO E. Effect of serotonin in migraine patients. Neurology. 1960 Feb;10:107–111. doi: 10.1212/wnl.10.2.107. [DOI] [PubMed] [Google Scholar]
  47. KING B. D., SOKOLOFF L., WECHSLER R. L. The effects of l-epinephrine and l-norepinephrine upon cerebral circulation and metabolism in man. J Clin Invest. 1952 Mar;31(3):273–279. doi: 10.1172/JCI102603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. KROG J. AUTONOMIC NERVOUS CONTROL OF THE CEREBRAL BLOOD FLOW IN MAN. J Oslo City Hosp. 1964 Feb;14:25–33. [PubMed] [Google Scholar]
  49. Kalsner S. Steroid potentiation of responses to sympathomimetic amines in aortic strips. Br J Pharmacol. 1969 Jul;36(3):582–593. doi: 10.1111/j.1476-5381.1969.tb08013.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. MOYER J. H., MORRIS G., SNYDER H., SMITH C. P. A comparison of the cerebral hemodynamic response to aramine and norepinephrine in the normotensive and hypotensive subject. Circulation. 1954 Aug;10(2):265–270. doi: 10.1161/01.cir.10.2.265. [DOI] [PubMed] [Google Scholar]
  51. Meyer J. S., Yoshida K., Sakamoto K. Autonomic control of cerebral blood flow measured by electromagnetic flowmeters. Neurology. 1967 Jul;17(7):638–648. doi: 10.1212/wnl.17.7.638. [DOI] [PubMed] [Google Scholar]
  52. Müller-Schweinitzer E. Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):113–118. doi: 10.1007/BF00498580. [DOI] [PubMed] [Google Scholar]
  53. Nelson E., Rennels M. Innervation of intracranial arteries. Brain. 1970;93(3):475–490. doi: 10.1093/brain/93.3.475. [DOI] [PubMed] [Google Scholar]
  54. Nelson E., Rennels M. Neuromuscular contacts in intracranial arteries of the cat. Science. 1970 Jan 16;167(3916):301–302. doi: 10.1126/science.167.3916.301. [DOI] [PubMed] [Google Scholar]
  55. Nielsen K. C., Owman C. Adrenergic innervation of pial arteries related to the circle of Willis in the cat. Brain Res. 1967 Dec;6(4):773–776. doi: 10.1016/0006-8993(67)90134-5. [DOI] [PubMed] [Google Scholar]
  56. Nielsen K. C., Owman C. Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res. 1971 Mar 19;27(1):33–42. doi: 10.1016/0006-8993(71)90370-2. [DOI] [PubMed] [Google Scholar]
  57. Nielsen K. C., Owman C., Sporrong B. Ultrastructure of the autonomic innervation apparatus in the main pial arteries of rats and cats. Brain Res. 1971 Mar 19;27(1):25–32. doi: 10.1016/0006-8993(71)90369-6. [DOI] [PubMed] [Google Scholar]
  58. O'Brien M. D. Cerebral blood changes in migraine. Headache. 1971 Jan;10(4):139–143. doi: 10.1111/j.1365-2524.1971.hed1004139.x. [DOI] [PubMed] [Google Scholar]
  59. OSTFELD A. M. Migraine headache: its physiology and biochemistry. JAMA. 1960 Oct 29;174:1188–1190. doi: 10.1001/jama.1960.63030090011010. [DOI] [PubMed] [Google Scholar]
  60. OSTFELD A. M., WOLFF H. G. Arterenol (norepinephrine) and vascular headache of the migraine type; studies on headache. AMA Arch Neurol Psychiatry. 1955 Aug;74(2):131–136. doi: 10.1001/archneurpsyc.1955.02330140015003. [DOI] [PubMed] [Google Scholar]
  61. Oldendorf W. H. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol. 1971 Dec;221(6):1629–1639. doi: 10.1152/ajplegacy.1971.221.6.1629. [DOI] [PubMed] [Google Scholar]
  62. PAASONEN M. K., VOGT M. The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain. J Physiol. 1956 Mar 28;131(3):617–626. doi: 10.1113/jphysiol.1956.sp005486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Phillips B. M. Oral contraceptive drugs and migraine. Br Med J. 1968 Apr 13;2(5597):99–99. doi: 10.1136/bmj.2.5597.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Raper A. J., Kontos H. A., Wei E. P., Patterson J. L., Jr Unresponsiveness of pial precapillary vessels to catecholamines and sympathetic nerve stimulation. Circ Res. 1972 Aug;31(2):257–266. doi: 10.1161/01.res.31.2.257. [DOI] [PubMed] [Google Scholar]
  65. SENSENBACH W., MADISON L., OCHS L. A comparison of the effects of 1-norepinephrine, synthetic 1-epinephrine, and U.S.P. epinephrine upon cerebral blood flow and metabolism in man. J Clin Invest. 1953 Mar;32(3):226–232. doi: 10.1172/JCI102731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. SICUTERI F. MAST CELLS AND THEIR ACTIVE SUBSTANCES: THEIR ROLE IN THE PATHOGENESIS OF MIGRAINE. Headache. 1963 Oct;3:86–92. doi: 10.1111/j.1526-4610.1963.hed0303086.x. [DOI] [PubMed] [Google Scholar]
  67. Sandler M. Migraine: a pulmonary disease? Lancet. 1972 Mar 18;1(7751):618–619. doi: 10.1016/s0140-6736(72)90412-6. [DOI] [PubMed] [Google Scholar]
  68. Sandler M., Youdim M. B., Hanington E. A phenylethylamine oxidising defect in migraine. Nature. 1974 Jul 26;250(464):335–337. doi: 10.1038/250335a0. [DOI] [PubMed] [Google Scholar]
  69. Saxena P. R., de Vlaam-Schluter G. M. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine. Headache. 1974 Jan;13(4):142–163. doi: 10.1111/j.1526-4610.1974.hed1304142.x. [DOI] [PubMed] [Google Scholar]
  70. Schanberg S. M., Stone R. A., Kirshner N., Gunnells J. C., Robinson R. R. Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension. Science. 1974 Feb 8;183(4124):523–525. doi: 10.1126/science.183.4124.523. [DOI] [PubMed] [Google Scholar]
  71. Schechter Y., Weinstock M. Beta-adrenoceptor blocking agents and responses to adrenaline and 5-hydroxytryptamine in rat isolated stomach and uterus. Br J Pharmacol. 1974 Oct;52(2):283–287. doi: 10.1111/j.1476-5381.1974.tb09711.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Sjaastad O., Stensrud P. Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis. Acta Neurol Scand. 1972;48(1):124–128. doi: 10.1111/j.1600-0404.1972.tb07532.x. [DOI] [PubMed] [Google Scholar]
  73. Skinhoj E. Hemodynamic studies within the brain during migraine. Arch Neurol. 1973 Aug;29(2):95–98. doi: 10.1001/archneur.1973.00490260039007. [DOI] [PubMed] [Google Scholar]
  74. Smith I., Kellow A. H., Hanington E. A clinical and biochemical correlation between tyramine and migraine headache. Headache. 1970 Jul;10(2):43–52. doi: 10.1111/j.1526-4610.1970.hed1002043.x. [DOI] [PubMed] [Google Scholar]
  75. Smith I., Kellow A. H., Mullen P. E., Hanington E. Dietary migraine and tyramine metabolism. Nature. 1971 Mar 26;230(5291):246–248. doi: 10.1038/230246a0. [DOI] [PubMed] [Google Scholar]
  76. Southgate J., Grant E. C., Pollard W., Pryse-Davies J., Sandler M. Cyclical variations in endometrial monoamine oxidase: correlation of histochemical and quantitative biochemical assays. Biochem Pharmacol. 1968 May;17(5):721–726. doi: 10.1016/0006-2952(68)90008-7. [DOI] [PubMed] [Google Scholar]
  77. Starke K., Altmann K. P. Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors. Neuropharmacology. 1973 Apr;12(4):339–347. doi: 10.1016/0028-3908(73)90093-2. [DOI] [PubMed] [Google Scholar]
  78. Sugden R. F. The action of indoramin and other compounds on the uptake of neurotransmitters into rat cortical slices. Br J Pharmacol. 1974 Jul;51(3):467–469. doi: 10.1111/j.1476-5381.1974.tb10687.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. TUNIS M. M., WOLFF H. G. Studies on headache; long-term observations of the reactivity of the cranial arteries in subjects with vascular headache of the migraine type. AMA Arch Neurol Psychiatry. 1953 Nov;70(5):551–557. [PubMed] [Google Scholar]
  80. Tandon R. N., Sur B. K., Nath K. Effect of reserpine injections in migrainous and normal control subjects, with estimations of urinary 5-hydroxyindoleacetic acid. Neurology. 1969 Nov;19(11):1073–1079. doi: 10.1212/wnl.19.11.1073. [DOI] [PubMed] [Google Scholar]
  81. Wahl M., Kuschinsky W., Bosse O., Olesen J., Lassen N. A., Ingvar D. H., Michaelis J., Thurau K. Effect of 1-norepinephrine on the diameter of pial arterioles and arteries in the cat. Circ Res. 1972 Aug;31(2):248–256. doi: 10.1161/01.res.31.2.248. [DOI] [PubMed] [Google Scholar]
  82. Wainscott G., Volans G. N., Wilkinson M., Faux G. A. Letter: Indoramin in prevention of migraine. Lancet. 1975 Jul 5;2(7923):32–33. doi: 10.1016/s0140-6736(75)92976-1. [DOI] [PubMed] [Google Scholar]
  83. Wainscott G., Volans G., Wilkinson M. Letter: Ergotamine-induced headaches. Br Med J. 1974 Jun 29;2(5921):724–724. doi: 10.1136/bmj.2.5921.724-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. White C., Richens A. Letter: Thymoxamine and spasticity. Lancet. 1974 Apr;1(7859):686–687. [PubMed] [Google Scholar]
  85. Wideroe T. E., Vigander T. Propranolol in the treatment of migraine. Br Med J. 1974 Jun 29;2(5921):699–701. doi: 10.1136/bmj.2.5921.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Youdim M. B., Carter S. B., Hanington E., Wilkinson M., Sandler M. Conjugation defect in tyramine-sensitive migraine. Nature. 1971 Mar 12;230(5289):127–128. doi: 10.1038/230127a0. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES